Veeva Systems (VEEV) – Q4 FY1/2026 Earnings Review
- Veeva posted a strong quarter: revenue $836M (+16% YoY), full-year FY2026 revenue $3.195B (+16%).
- Vault CRM has 125+ live customers; 10 of top-20 biopharma committed globally (~14 expected ultimately). First AI agents went live in production (Vault CRM and PromoMats), with Safety agents due April 2026.
- FY2027 guidance of $3.585-3.600B (+13%) reflects modest deceleration.
- Read on for detailed financials, technical analysis and rating.
DISCLAIMER: This note is intended for US recipients only and, in particular, is not directed at, nor intended to be relied upon by any UK recipients. Any information or analysis in this note is not an offer to sell or the solicitation of an offer to buy any securities. Nothing in this note is intended to be investment advice and nor should it be relied upon to make investment decisions. Read our full disclaimer, here.
Q4 Beat Caps a Strong Fiscal Year; AI Agent Rollout Begins
by Abhishek Singh
Veeva Systems achieved a broad Q4 beat in last fiscal year, confirming the durability of its life-sciences cloud franchise even as CRM migration headwinds dominated the investor narrative. Below are the headline numbers.
A notable development reported during the earnings call was regarding Veeva's first generation of AI agents, which are now live in production since December 2025. Veeva’s management was measured in framing, with CEO Peter Gassner describing the agentic opportunity as 'substantial' for Veeva and life sciences but was equally clear that core systems of record like Veeva would incorporate AI rather than be replaced by it. Monetization would be usage-based with material contribution expected only post-FY2027, and Gassner himself flagged that 'it's early days.'